Skip to Content

163 Results Found

  • Article
  • Open Access
25 Citations
5,849 Views
12 Pages

Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses

  • Hye Jin Shin,
  • Mi-Hwa Kim,
  • Joo-Youn Lee,
  • Insu Hwang,
  • Gun Young Yoon,
  • Hae Soo Kim,
  • Young-Chan Kwon,
  • Dae-Gyun Ahn,
  • Kyun-Do Kim and
  • Chonsaeng Kim
  • + 2 authors

Zika virus (ZIKV), which is associated with severe diseases in humans, has spread rapidly and globally since its emergence. ZIKV and dengue virus (DENV) are closely related, and antibody-dependent enhancement (ADE) of infection between cocirculating...

(This article belongs to the Special Issue Recent Advances in Antivirals for Emerging Viruses)
  • Article
  • Open Access
19 Citations
8,832 Views
13 Pages

In Vitro Evaluation of Novel Inhibitors against the NS2B-NS3 Protease of Dengue Fever Virus Type 4

  • Thi Thanh Hanh Nguyen,
  • Sun Lee,
  • Hsi-Kai Wang,
  • Hsin-Yen Chen,
  • Ying-Ta Wu,
  • Simon C. Lin,
  • Do-Won Kim and
  • Doman Kim

13 December 2013

The discovery of potent therapeutic compounds against dengue virus is urgently needed. The NS2B-NS3 protease (NS2B-NS3pro) of dengue fever virus carries out all enzymatic activities needed for polyprotein processing and is considered to be amenable t...

(This article belongs to the Special Issue In-Silico Drug Design and In-Silico Screening)
  • Article
  • Open Access
1 Citations
1,891 Views
25 Pages

Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease

  • Josè Starvaggi,
  • Carla Di Chio,
  • Johannes Lang,
  • Valentina Belgiovine,
  • Daniela Trisciuzzi,
  • Santo Previti,
  • Christian Klein,
  • Orazio Nicolotti,
  • Salvatore Di Maro and
  • Roberta Ettari
  • + 1 author

22 December 2025

Background: In this study, we report a novel series of proline- and pipecolic acid-based small molecules designed as allosteric inhibitors of the NS2B/NS3 serine proteases from dengue and Zika viruses, key targets in antiviral drug discovery. Results...

(This article belongs to the Special Issue Platform Technologies and Emerging Modalities for Neglected Tropical Disease Therapeutics)
  • Review
  • Open Access
14 Citations
5,882 Views
27 Pages

27 August 2024

Orthoflaviviruses, including zika (ZIKV), West Nile (WNV), and dengue (DENV) virus, induce severely debilitating infections and contribute significantly to the global disease burden, yet no clinically approved antiviral treatments exist. This review...

(This article belongs to the Special Issue Featured Papers in Medicinal Chemistry II)
  • Article
  • Open Access
8 Citations
3,617 Views
16 Pages

Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays

  • Lucianna H. Santos,
  • Rafael E. O. Rocha,
  • Diego L. Dias,
  • Beatriz M. R. M. Ribeiro,
  • Mateus Sá M. Serafim,
  • Jônatas S. Abrahão and
  • Rafaela S. Ferreira

19 September 2023

The NS2B-NS3 protease (NS2B-NS3pro) is regarded as an interesting molecular target for drug design, discovery, and development because of its essential role in the Zika virus (ZIKV) cycle. Although no NS2B-NS3pro inhibitors have reached clinical tria...

(This article belongs to the Special Issue New Perspectives on Chemoinformatics and Drug Design)
  • Review
  • Open Access
33 Citations
9,070 Views
22 Pages

In the global pandemic scenario, dengue and zika viruses (DENV and ZIKV, respectively), both mosquito-borne members of the flaviviridae family, represent a serious health problem, and considering the absence of specific antiviral drugs and available...

(This article belongs to the Section Macromolecules)
  • Article
  • Open Access
17 Citations
4,418 Views
12 Pages

Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in “Super-Open” Conformation

  • Ittipat Meewan,
  • Sergey A. Shiryaev,
  • Julius Kattoula,
  • Chun-Teng Huang,
  • Vivian Lin,
  • Chiao-Han Chuang,
  • Alexey V. Terskikh and
  • Ruben Abagyan

30 April 2023

The Zika virus (ZIKV), a member of the Flaviviridae family, is considered a major health threat causing multiple cases of microcephaly in newborns and Guillain-Barré syndrome in adults. In this study, we targeted a transient, deep, and hydroph...

(This article belongs to the Special Issue Molecular Biology of RNA Viruses)
  • Proceeding Paper
  • Open Access
3 Citations
3,283 Views
9 Pages

In Silico Study of 5,7-Dimethoxycoumarin and p-Coumaric Acid in Carica papaya Leaves as Dengue Virus Type 2 Protease Inhibitors

  • Samith Rathnayake,
  • Ayesh Madushanka,
  • N.D. Asha Dilrukshi Wijegunawardana,
  • Harthika Mylvaganam,
  • Ajith Rathnayake,
  • Eranga Geethanjana Perera,
  • Ishara Jayamanna,
  • Priyantha Chandrasena,
  • Ahinsa Ranaweera and
  • Chathuranga Bamunuarachchige
  • + 1 author

2 December 2020

Dengue virus is a serious public health issue in tropical and subtropical regions. The global incidence of dengue necessitates the potent antiviral medication for the prevention of proliferation of the virus inside the human body. The DEN2 NS2B/NS3 p...

(This article belongs to the Proceedings of The 1st International Electronic Conference on Biomolecules: Natural and Bio-Inspired Therapeutics for Human Diseases)
  • Article
  • Open Access
2 Citations
2,010 Views
40 Pages

Distinct Characteristic Binding Modes of Benzofuran Core Inhibitors to Diverse Genotypes of Hepatitis C Virus NS5B Polymerase: A Molecular Simulation Study

  • Di Han,
  • Fang Zhao,
  • Yifan Chen,
  • Yiwei Xue,
  • Ke Bao,
  • Yuxiao Chang,
  • Jiarui Lu,
  • Meiting Wang,
  • Taigang Liu and
  • Yongtao Xu
  • + 2 authors

The benzofuran core inhibitors HCV-796, BMS-929075, MK-8876, compound 2, and compound 9B exhibit good pan-genotypic activity against various genotypes of NS5B polymerase. To elucidate their mechanism of action, multiple molecular simulation methods w...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
20 Citations
7,919 Views
15 Pages

27 March 2012

Using a support vector machine (SVM), three classification models were built to predict whether a compound is an active or weakly active inhibitor based on a dataset of 386 hepatitis C virus (HCV) NS5B polymerase NNIs (non-nucleoside analogue inhibit...

  • Article
  • Open Access
9 Citations
2,869 Views
22 Pages

An Exploration of the Inhibitory Mechanism of Rationally Screened Benzofuran-1,3,4-Oxadiazoles and-1,2,4-Triazoles as Inhibitors of NS5B RdRp Hepatitis C Virus through Pharmacoinformatic Approaches

  • Ali Irfan,
  • Shah Faisal,
  • Sajjad Ahmad,
  • Muhammad Jawwad Saif,
  • Ameer Fawad Zahoor,
  • Samreen Gul Khan,
  • Jamila Javid,
  • Sami A. Al-Hussain,
  • Muhammed Tilahun Muhammed and
  • Magdi E. A. Zaki

17 November 2023

Benzofuran, 1,3,4-oxadiazole, and 1,2,4-triazole are privileged heterocyclic moieties that display the most promising and wide spectrum of biological activities against a wide variety of diseases. In the current study, benzofuran-1,3,4-oxadiazole BF1...

(This article belongs to the Special Issue Small Molecule Drug Discovery with Anti-microbial and Anti-cancer Properties)
  • Review
  • Open Access
90 Citations
10,765 Views
27 Pages

Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B

  • Megan H. Powdrill,
  • Jean A. Bernatchez and
  • Matthias Götte

28 September 2010

More than 20 years after the identification of the hepatitis C virus (HCV) as a novel human pathogen, the only approved treatment remains a combination of pegylated interferon-α and ribavirin. This rather non-specific therapy is associated with sever...

(This article belongs to the Special Issue Antivirals Against Hepatitis C Virus)
  • Article
  • Open Access
5 Citations
5,465 Views
22 Pages

Structural Insights into Plasticity and Discovery of Flavonoid Allosteric Inhibitors of Flavivirus NS2B–NS3 Protease

  • Marielena Vogel Saivish,
  • Gabriela de Lima Menezes,
  • Vivaldo Gomes da Costa,
  • Liliane Nebo,
  • Gislaine Celestino Dutra da Silva,
  • Carolina Colombelli Pacca,
  • Rafael Elias Marques,
  • Maurício Lacerda Nogueira and
  • Roosevelt Alves Da Silva

1 February 2023

Flaviviruses are among the most critical pathogens in tropical regions; they cause various severe diseases in developing countries but are not restricted to these countries. The development of antiviral therapeutics is crucial for managing flavivirus...

(This article belongs to the Special Issue Molecular Structure and Simulation in Biological System)
  • Article
  • Open Access
9 Citations
3,813 Views
18 Pages

Discovery of Potent Dengue Virus NS2B-NS3 Protease Inhibitors Among Glycyrrhizic Acid Conjugates with Amino Acids and Dipeptides Esters

  • Yu-Feng Lin,
  • Hsueh-Chou Lai,
  • Chen-Sheng Lin,
  • Ping-Yi Hung,
  • Ju-Ying Kan,
  • Shih-Wen Chiu,
  • Chih-Hao Lu,
  • Svetlana F. Petrova,
  • Lidia Baltina and
  • Cheng-Wen Lin

17 December 2024

This study investigated a library of known and novel glycyrrhizic acid (GL) conjugates with amino acids and dipeptide esters, as inhibitors of the DENV NS2B-NS3 protease. We utilized docking algorithms to evaluate the interactions of these GL derivat...

(This article belongs to the Special Issue Recent Advances in Anti-HCV, Anti-HBV and Anti-flavivirus Agents)
  • Article
  • Open Access
11 Citations
4,124 Views
17 Pages

24 December 2024

Dengue, West Nile, Zika, Yellow fever, and Japanese encephalitis viruses persist as significant global health threats. The development of new therapeutic strategies based on inhibiting essential viral enzymes or viral–host protein interactions...

(This article belongs to the Special Issue Recent Advances in Anti-HCV, Anti-HBV and Anti-flavivirus Agents)
  • Article
  • Open Access
3 Citations
1,471 Views
14 Pages

Identification of Sulfonamide-Vinyl Sulfone/Chalcone and Berberine-Cinnamic Acid Hybrids as Potent DENV and ZIKV NS2B/NS3 Allosteric Inhibitors

  • Panupong Mahalapbutr,
  • Kowit Hengphasatporn,
  • Wachirapol Manimont,
  • Ladawan Vajarintarangoon,
  • Yasuteru Shigeta,
  • Nayana Bhat,
  • Thitinan Aiebchun,
  • Bodee Nutho,
  • Supot Hannongbua and
  • Thanyada Rungrotmongkol

4 December 2025

Dengue virus (DENV) and Zika virus (ZIKV) are flaviviruses transmitted by Aedes spp. mosquitoes, causing a spectrum of symptoms ranging from mild fevers and joint pain to severe damage to vital organs, including the kidneys, brain, and liver. Unfortu...

(This article belongs to the Special Issue In Silico Methods of Assessing the Therapeutic Potential of Natural Substances)
  • Article
  • Open Access
43 Citations
4,813 Views
15 Pages

Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches

  • Hafiz Muzzammel Rehman,
  • Muhammad Sajjad,
  • Muhammad Akhtar Ali,
  • Roquyya Gul,
  • Muhammad Irfan,
  • Muhammad Naveed,
  • Munir Ahmad Bhinder,
  • Muhammad Usman Ghani,
  • Nadia Hussain and
  • Mahjabeen Saleem
  • + 2 authors

5 January 2023

Zika virus (ZIKV) pandemic and its implication in congenital malformations and severe neurological disorders had created serious threats to global health. ZIKV is a mosquito-borne flavivirus which spread rapidly and infect a large number of people in...

  • Article
  • Open Access
25 Citations
5,019 Views
20 Pages

A Computational Approach Applied to the Study of Potential Allosteric Inhibitors Protease NS2B/NS3 from Dengue Virus

  • Renato A. da Costa,
  • João A. P. da Rocha,
  • Alan S. Pinheiro,
  • Andréia do S. S. da Costa,
  • Elaine C. M. da Rocha,
  • Rai. C. Silva,
  • Arlan da S. Gonçalves,
  • Cleydson B. R. Santos and
  • Davi do S. B. Brasil

27 June 2022

Dengue virus (DENV) is a danger to more than 400 million people in the world, and there is no specific treatment. Thus, there is an urgent need to develop an effective method to combat this pathology. NS2B/NS3 protease is an important biological targ...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
49 Citations
11,419 Views
12 Pages

Design of New Competitive Dengue Ns2b/Ns3 Protease Inhibitors—A Computational Approach

  • Neni Frimayanti,
  • Chin Fei Chee,
  • Sharifuddin M. Zain and
  • Noorsaadah Abd. Rahman

9 February 2011

Dengue is a serious disease which has become a global health burden in the last decade. Currently, there are no approved vaccines or antiviral therapies to combat the disease. The increasing spread and severity of the dengue virus infection emphasize...

(This article belongs to the Section Physical Chemistry, Theoretical and Computational Chemistry)
  • Article
  • Open Access
6 Citations
4,199 Views
30 Pages

Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors

  • Tamer Nasr,
  • Ahmed M. Aboshanab,
  • George Mpekoulis,
  • Antonios Drakopoulos,
  • Niki Vassilaki,
  • Grigoris Zoidis,
  • Khaled A. M. Abouzid and
  • Wafaa Zaghary

12 December 2022

Chronic hepatitis C virus (HCV) infections are a worldwide medical problem responsible for diverse types of liver diseases. The NS5B polymerase enzyme has become a very interesting target for the development of anti-HCV drugs owing to its fundamental...

(This article belongs to the Special Issue Antiviral Therapeutics for Emerging Viruses)
  • Article
  • Open Access
2 Citations
4,361 Views
31 Pages

Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors

  • Jehad Hamdy,
  • Nouran Emadeldin,
  • Mostafa M. Hamed,
  • Efseveia Frakolaki,
  • Sotirios Katsamakas,
  • Niki Vassilaki,
  • Grigoris Zoidis,
  • Anna K. H. Hirsch,
  • Mohammad Abdel-Halim and
  • Ashraf H. Abadi

In today’s global plan to completely eradicate hepatitis C virus (HCV), the essential list of medications used for HCV treatment are direct-acting antivirals (DAAs), as interferon-sparing regimens have become the standard-of-care (SOC) treatment. HCV...

(This article belongs to the Special Issue Antiviral Drugs 2021)
  • Article
  • Open Access
7 Citations
4,170 Views
19 Pages

Riboflavin, a Potent Neuroprotective Vitamin: Focus on Flavivirus and Alphavirus Proteases

  • Raphael J. Eberle,
  • Danilo S. Olivier,
  • Marcos S. Amaral,
  • Carolina C. Pacca,
  • Mauricio L. Nogueira,
  • Raghuvir K. Arni,
  • Dieter Willbold and
  • Monika A. Coronado

Several neurotropic viruses are members of the flavivirus and alphavirus families. Infections caused by these viruses may cause long-term neurological sequelae in humans. The continuous emergence of infections caused by viruses around the world, such...

(This article belongs to the Special Issue Emerging Viruses and Antiviral Drugs)
  • Review
  • Open Access
38 Citations
7,453 Views
15 Pages

Antiviral Agents against Flavivirus Protease: Prospect and Future Direction

  • Subodh K. Samrat,
  • Jimin Xu,
  • Zhong Li,
  • Jia Zhou and
  • Hongmin Li

25 February 2022

Flaviviruses cause a significant amount of mortality and morbidity, especially in regions where they are endemic. A recent example is the outbreak of Zika virus throughout the world. Development of antiviral drugs against different viral targets is a...

(This article belongs to the Special Issue Emerging and/or Zoonotic Viral Infections)
  • Article
  • Open Access
17 Citations
3,946 Views
15 Pages

Promising Natural Compounds against Flavivirus Proteases: Citrus Flavonoids Hesperetin and Hesperidin

  • Raphael J. Eberle,
  • Danilo S. Olivier,
  • Marcos S. Amaral,
  • Dieter Willbold,
  • Raghuvir K. Arni and
  • Monika A. Coronado

14 October 2021

Ubiquitous in citrus plants, Hesperidin and Hesperetin flavanones possess several biological functions, including antiviral activity. Arbovirus infections pose an ever-increasing threat to global healthcare systems. Among the severe arboviral infecti...

(This article belongs to the Section Phytochemistry)
  • Article
  • Open Access
8 Citations
3,928 Views
28 Pages

ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B

  • Maroua Fattouche,
  • Salah Belaidi,
  • Oussama Abchir,
  • Walid Al-Shaar,
  • Khaled Younes,
  • Muneerah Mogren Al-Mogren,
  • Samir Chtita,
  • Fatima Soualmia and
  • Majdi Hochlaf

18 December 2024

Background/Objectives: RNA polymerase (NS5B), serves as a crucial target for pharmaceutical interventions aimed at combating the hepatitis C virus (HCV), which poses significant health challenges worldwide. The present research endeavors to explore a...

(This article belongs to the Special Issue Application of 2D and 3D-QSAR Models in Drug Design)
  • Article
  • Open Access
7 Citations
3,174 Views
12 Pages

Discovery of Terpenes as Novel HCV NS5B Polymerase Inhibitors via Molecular Docking

  • Tomasz M. Karpiński,
  • Marcin Ożarowski,
  • Pedro J. Silva,
  • Mark Stasiewicz,
  • Rahat Alam and
  • Abdus Samad

Hepatitis C virus (HCV) is a dangerous virus that is responsible for a large number of infections and deaths worldwide. In the treatment of HCV, it is important that the drugs are effective and do not have additional hepatotoxic effects. The aim of t...

(This article belongs to the Special Issue Advances in HCV Research)
  • Article
  • Open Access
2 Citations
5,384 Views
19 Pages

Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein

  • Ekaterina I. Lesnova,
  • Olga V. Masalova,
  • Kristina Yu. Permyakova,
  • Vyacheslav V. Kozlov,
  • Tatyana N. Nikolaeva,
  • Alexander V. Pronin,
  • Vladimir T. Valuev-Elliston,
  • Alexander V. Ivanov and
  • Alla A. Kushch

Hepatitis C virus (HCV) is one of the main triggers of chronic liver disease. Despite tremendous progress in the HCV field, there is still no vaccine against this virus. Potential vaccines can be based on its recombinant proteins. To increase the hum...

(This article belongs to the Special Issue Hepatitis Virus Infection and Molecular Research 2022)
  • Article
  • Open Access
16 Citations
9,743 Views
12 Pages

27 June 2011

Globally, over 170 million people (ca. 3% of the World’s population) are infected with the hepatitis C virus (HCV), which can cause serious liver diseases such as chronic hepatitis, evolving into subsequent health problems. Driven by the need to dete...

(This article belongs to the Special Issue Bioassays)
  • Article
  • Open Access
21 Citations
5,268 Views
18 Pages

Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches

  • Jun-Ping Quek,
  • Zheng Ser,
  • Bing Liang Alvin Chew,
  • Xin Li,
  • Lili Wang,
  • Radoslaw M. Sobota,
  • Dahai Luo and
  • Wint Wint Phoo

30 June 2022

Diseases caused by flaviviruses such as dengue virus (DENV) and West Nile Virus (WNV), are a serious threat to public health. The flavivirus single-stranded RNA genome is translated into a polyprotein which is cleaved into three structural proteins a...

(This article belongs to the Special Issue Viruses 2022 - At the Leading Edge of Virology Research)
  • Review
  • Open Access
107 Citations
15,189 Views
19 Pages

Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance

  • Auda A. Eltahla,
  • Fabio Luciani,
  • Peter A. White,
  • Andrew R. Lloyd and
  • Rowena A. Bull

29 September 2015

The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries. Controlling the spread of HCV through behavioural prevention strategies has met with limited success...

(This article belongs to the Special Issue HCV Drug Resistance)
  • Commentary
  • Open Access
13 Citations
7,124 Views
3 Pages

10 January 2017

Zika virus (ZIKV) is the cause of a significant viral disease affecting humans, which has spread throughout many South American countries and has also become a threat to Southeastern Asia. This commentary discusses the article “Crystal structure of u...

(This article belongs to the Special Issue Advances in Flavivirus Research)
  • Article
  • Open Access
5 Citations
2,806 Views
16 Pages

Quantum Biochemistry and MM-PBSA Description of the ZIKV NS2B-NS3 Protease: Insights into the Binding Interactions beyond the Catalytic Triad Pocket

  • Valdir Ferreira de Paula Junior,
  • Mauricio Fraga van Tilburg,
  • Pablo Abreu Morais,
  • Francisco Franciné Maia Júnior,
  • Elza Gadelha Lima,
  • Victor Tabosa dos Santos Oliveira,
  • Maria Izabel Florindo Guedes,
  • Ewerton Wagner Santos Caetano and
  • Valder Nogueira Freire

3 September 2022

The Zika virus protease NS2B-NS3 has a binding site formed with the participation of a H51-D75-S135 triad presenting two forms, active and inactive. Studies suggest that the inactive conformation is a good target for the design of inhibitors. In this...

(This article belongs to the Special Issue Recent Advances of Biochemistry and Molecular Biology of Infectious Diseases)
  • Article
  • Open Access
2 Citations
3,291 Views
27 Pages

Within the field of Philippine folkloric medicine, the utilization of indigenous plants like Euphorbia hirta (tawa-tawa), Carica papaya (papaya), and Psidium guajava (guava) as potential dengue remedies has gained attention. Yet, limited research exi...

(This article belongs to the Special Issue New Insight: Enzymes as Targets for Drug Development, 2nd Edition)
  • Article
  • Open Access
5 Citations
3,623 Views
19 Pages

An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding

  • Haiyan Wang,
  • Benoit Gallet,
  • Christine Moriscot,
  • Mylène Pezet,
  • Christine Chatellard,
  • Jean-Philippe Kleman,
  • Heinrich Göttlinger,
  • Winfried Weissenhorn and
  • Cécile Boscheron

22 November 2023

HIV-1 budding as well as many other cellular processes require the Endosomal Sorting Complex Required for Transport (ESCRT) machinery. Understanding the architecture of the native ESCRT-III complex at HIV-1 budding sites is limited due to spatial res...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Article
  • Open Access
9 Citations
3,291 Views
15 Pages

Novel Aporphine- and Proaporphine–Clerodane Hybrids Identified from the Barks of Taiwanese Polyalthia longifolia (Sonn.) Thwaites var. pendula with Strong Anti-DENV2 Activity

  • I-Wen Lo,
  • Geng-You Liao,
  • Jin-Ching Lee,
  • Chi-I Chang,
  • Yang-Chang Wu,
  • Yen-Yu Chen,
  • Shang-Pin Liu,
  • Huey-Jen Su,
  • Chih-I Liu and
  • Chia-Ching Liaw
  • + 4 authors

30 September 2022

Hybrid natural products produced via mixed biosynthetic pathways are unique and often surprise one with unexpected medicinal properties in addition to their fascinating structural complexity/diversity. In view of chemical structures, hybridization is...

(This article belongs to the Special Issue Antiviral Compounds in Medicinal Plants)
  • Article
  • Open Access
27 Citations
6,617 Views
16 Pages

Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study

  • Mst. Sharmin Sultana Shimu,
  • Shafi Mahmud,
  • Trina Ekwati Tallei,
  • Saad Ahmed Sami,
  • Ahmad Akroman Adam,
  • Uzzal Kumar Acharjee,
  • Gobindo Kumar Paul,
  • Talha Bin Emran,
  • Shahriar Zaman and
  • Bonglee Kim
  • + 8 authors

20 January 2022

The spread of the Dengue virus over the world, as well as multiple outbreaks of different serotypes, has resulted in a large number of deaths and a medical emergency, as no viable medications to treat Dengue virus patients have yet been found. In thi...

(This article belongs to the Special Issue Computational Strategy for Drug Design)
  • Article
  • Open Access
32 Citations
6,663 Views
11 Pages

An Antiviral Peptide from Alopecosa nagpag Spider Targets NS2B–NS3 Protease of Flaviviruses

  • Mengyao Ji,
  • Tengyu Zhu,
  • Meichen Xing,
  • Ning Luan,
  • James Mwangi,
  • Xiuwen Yan,
  • Guoxiang Mo,
  • Mingqiang Rong,
  • Bowen Li and
  • Lin Jin
  • + 1 author

10 October 2019

Flaviviruses are single-stranded RNA viruses predominantly transmitted by the widely distributed Aedes mosquitoes in nature. As important human pathogens, the geographic reach of Flaviviruses and their threats to public health are increasing, but the...

(This article belongs to the Special Issue Animal Venoms and Their Components: Molecular Mechanisms of Action)
  • Short Note
  • Open Access
8 Citations
4,429 Views
8 Pages

3-(3,4-Dimethoxyphenyl)-5-(2-fluorophenyl)-1-phenyl-4,5-dihydro-1H-pyrazole

  • Adel Zamri,
  • Hilwan Y. Teruna,
  • Sri Wulansari,
  • Noval Herfindo,
  • Neni Frimayanti and
  • Ihsan Ikhtiarudin

12 November 2019

A new analogue of fluorinated pyrazoline (compound 1) has been synthesized via one-pot three-component reaction in a sealed-vessel reactor, Monowave 50. The structure of compound 1 has been established by spectroscopy analysis, including UV, FT-IR, H...

(This article belongs to the Section Organic Synthesis and Biosynthesis)
  • Article
  • Open Access
13 Citations
4,878 Views
17 Pages

The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses

  • Mônika A. Coronado,
  • Ian Gering,
  • Marc Sevenich,
  • Danilo S. Olivier,
  • Mohammadamin Mastalipour,
  • Marcos S. Amaral,
  • Dieter Willbold and
  • Raphael J. Eberle

Arboviruses such as Dengue, yellow fever, West Nile, and Zika are flaviviruses vector-borne RNA viruses transmitted biologically among vertebrate hosts by blood-taking vectors. Many flaviviruses are associated with neurological, viscerotropic, and he...

(This article belongs to the Special Issue Bioactive Molecules from Plants: Discovery and Pharmaceutical Applications (Volume II))
  • Article
  • Open Access
21 Citations
5,514 Views
25 Pages

Discovery of Bispecific Lead Compounds from Azadirachta indica against ZIKA NS2B-NS3 Protease and NS5 RNA Dependent RNA Polymerase Using Molecular Simulations

  • Sanjay Kumar,
  • Sherif A. El-Kafrawy,
  • Shiv Bharadwaj,
  • S. S. Maitra,
  • Thamir A. Alandijany,
  • Arwa A. Faizo,
  • Aiah M. Khateb,
  • Vivek Dhar Dwivedi and
  • Esam I. Azhar

15 April 2022

Zika virus (ZIKV) has been characterized as one of many potential pathogens and placed under future epidemic outbreaks by the WHO. However, a lack of potential therapeutics can result in an uncontrolled pandemic as with other human pandemic viruses....

(This article belongs to the Section Chemical Biology)
  • Article
  • Open Access
5 Citations
1,358 Views
16 Pages

Novel Thiazolidinedione Derivatives as Potential ZIKV Antiviral Inhibitors

  • Isabella Luiza Ralph de Oliveira,
  • José Arion da Silva Moura,
  • Patricia Recordon-Pinson,
  • Floriane Lagadec,
  • Michelle Melgarejo da Rosa,
  • Sayonara Maria Calado Gonçalves,
  • Douglas Carvalho Francisco Viana,
  • Paulo André Teixeira de Moraes Gomes,
  • Marina Galdino da Rocha Pitta and
  • Maira Galdino da Rocha Pitta
  • + 4 authors

Zika virus (ZIKV) remains a pressing global health concern due to its association with congenital Zika syndrome and the current lack of approved antiviral therapies. In this study, we evaluated the antiviral activity of three novel thiazolidinedione...

(This article belongs to the Special Issue Emerging Infectious Diseases and Multidrug Resistance)
  • Article
  • Open Access
7 Citations
2,902 Views
20 Pages

15 August 2024

Zika virus infection is a mosquito-borne viral disease that has become a global health concern recently. Zika virus belongs to the Flavivirus genus and is primarily transmitted by Aedes mosquitoes. Prevention of Zika virus infection involves avoiding...

(This article belongs to the Special Issue Application of 2D and 3D-QSAR Models in Drug Design)
  • Review
  • Open Access
19 Citations
8,160 Views
31 Pages

Inhibitory Potential of Chromene Derivatives on Structural and Non-Structural Proteins of Dengue Virus

  • Babitha Thekkiniyedath Dharmapalan,
  • Raja Biswas,
  • Sathianarayanan Sankaran,
  • Baskar Venkidasamy,
  • Muthu Thiruvengadam,
  • Ginson George,
  • Maksim Rebezov,
  • Gokhan Zengin,
  • Monica Gallo and
  • Mohammad Ali Shariati
  • + 2 authors

28 November 2022

Dengue fever is a mosquito-borne viral disease that has become a serious health issue across the globe. It is caused by a virus of the Flaviviridae family, and it comprises five different serotypes (DENV-1 to DENV-5). As there is no specific medicine...

(This article belongs to the Section Animal Viruses)
  • Article
  • Open Access
1 Citations
2,885 Views
23 Pages

Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia

  • Petra Simicic,
  • Anamarija Slovic,
  • Leona Radmanic,
  • Adriana Vince and
  • Snjezana Zidovec Lepej

Molecular epidemiology of hepatitis C virus (HCV) is exceptionally complex due to the highly diverse HCV genome. Genetic diversity, transmission dynamics, and epidemic history of the most common HCV genotypes were inferred by population sequencing of...

(This article belongs to the Special Issue Molecular Diagnostic and Epidemiology of Viral Infections)
  • Review
  • Open Access
48 Citations
16,576 Views
16 Pages

17 February 2022

Dengue virus is an important human pathogen threating people, especially in tropical and sub-tropical regions. The viral genome has one open reading frame and encodes one polyprotein which can be processed into structural and nonstructural (NS) prote...

(This article belongs to the Special Issue The Structure, Dynamics and Function of Membrane Proteins)
  • Review
  • Open Access
31 Citations
7,293 Views
12 Pages

The Future of HCV Therapy: NS4B as an Antiviral Target

  • Hadas Dvory-Sobol,
  • Philip S. Pang and
  • Jeffrey S. Glenn

10 November 2010

Chronic hepatitis C virus (HCV) infection is a major worldwide cause of liver disease, including cirrhosis and hepatocellular carcinoma. It is estimated that more than 170 million individuals are infected with HCV, with three to four million new case...

(This article belongs to the Special Issue Antivirals Against Hepatitis C Virus)
  • Article
  • Open Access
11 Citations
6,914 Views
20 Pages

16 June 2017

Allosteric inhibitors of hepatitis C virus (HCV) non-structural protein 5B (NS5B) polymerase are effective for treatment of genotype 1, although their mode of action and potential to inhibit other isolates and genotypes are not well established. We h...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
1 Citations
573 Views
14 Pages

A Database-Derived Global Overview of HCV Resistance-Associated Substitutions: Characterizing Genotypic, Regional, and Temporal Heterogeneity

  • Gabriela Tavares Marinho Nunes,
  • Thaís Barbosa Ferreira Sant’Anna and
  • Natalia Motta de Araujo

Direct-acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) therapy, yet resistance-associated substitutions (RASs) remain a concern in specific clinical contexts. Here, we present a database-derived global overview of HCV RASs by ana...

(This article belongs to the Special Issue Viral Infections and Host Antiviral Responses: Molecular Mechanisms and Molecular Regulation)
  • Article
  • Open Access
5 Citations
5,407 Views
17 Pages

Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus

  • Dandan Liu,
  • Tanya P. Ndongwe,
  • Juan Ji,
  • Andrew D. Huber,
  • Eleftherios Michailidis,
  • Charles M. Rice,
  • Robert Ralston,
  • Philip R. Tedbury and
  • Stefan G. Sarafianos

17 April 2023

Several direct-acting antivirals (DAAs) are available, providing interferon-free strategies for a hepatitis C cure. In contrast to DAAs, host-targeting agents (HTAs) interfere with host cellular factors that are essential in the viral replication cyc...

(This article belongs to the Special Issue Boosting Flavivirus Research: A Pandengue Net Initiative)
  • Article
  • Open Access
11 Citations
3,960 Views
18 Pages

Prevalence and Factors Related to Natural Resistance-Associated Substitutions to Direct-Acting Antivirals in Patients with Genotype 1 Hepatitis C Virus Infection

  • Isabella Esposito,
  • Sebastián Marciano,
  • Leila Haddad,
  • Omar Galdame,
  • Alejandra Franco,
  • Adrián Gadano,
  • Diego Flichman and
  • Julieta Trinks

21 December 2018

This study aimed to assess the prevalence of natural resistance-associated substitutions (RASs) to NS3, NS5A and NS5B inhibitors in 86 genotype 1 Hepatitis C Virus (HCV)-infected patients from Buenos Aires, Argentina, and to determine their effect on...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)

of 4